Genetic linkage of hyper-IgE syndrome to chromosome 4.

PubWeight™: 2.63‹?› | Rank: Top 1%

🔗 View Article (PMC 1377980)

Published in Am J Hum Genet on September 01, 1999

Authors

B Grimbacher1, A A Schäffer, S M Holland, J Davis, J I Gallin, H L Malech, T P Atkinson, B H Belohradsky, R H Buckley, F Cossu, T Español, B Z Garty, N Matamoros, L A Myers, R P Nelson, H D Ochs, E D Renner, N Wellinghausen, J M Puck

Author Affiliations

1: Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-4442, USA.

Articles citing this

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature (2008) 8.17

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med (2008) 4.76

Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med (2009) 4.52

Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol (2009) 3.13

Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol (2008) 2.50

The hyper-IgE syndromes. Immunol Allergy Clin North Am (2008) 2.19

A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity (2011) 2.15

Deficient T Cell Receptor Excision Circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening. Clin Immunol (2011) 1.64

Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol (2010) 1.36

Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) (2012) 1.31

Hyper-IgE syndrome update. Ann N Y Acad Sci (2012) 1.31

An update on the hyper-IgE syndromes. Arthritis Res Ther (2012) 1.23

An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family. Am J Hum Genet (2001) 1.18

The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol (2015) 1.15

Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome. Clin Exp Immunol (2005) 1.12

Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J Exp Med (2011) 1.06

The molecular pathology of primary immunodeficiencies. J Mol Diagn (2004) 0.98

Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections. Curr Opin HIV AIDS (2010) 0.98

Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients. J Clin Immunol (2012) 0.95

Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol (2011) 0.95

Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol (2011) 0.90

A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin Exp Immunol (2009) 0.90

Hyperimmunoglobulin E syndromes in pediatrics. Curr Opin Pediatr (2011) 0.89

The hyper-IgE syndrome is not caused by a microdeletion syndrome. Immunogenetics (2007) 0.89

The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency. Orphanet J Rare Dis (2011) 0.89

Genetic interstitial lung disease. Clin Chest Med (2011) 0.89

No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome. J Clin Immunol (2005) 0.87

Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography. AJR Am J Roentgenol (2009) 0.85

The Ying and Yang of STAT3 in Human Disease. J Clin Immunol (2015) 0.82

Educational paper: syndromic forms of primary immunodeficiency. Eur J Pediatr (2011) 0.82

Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol (2013) 0.81

Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome. J Clin Immunol (2015) 0.80

Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J Pediatr (2010) 0.80

Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology. J Clin Immunol (2014) 0.79

The Hyper-IgE Syndromes: Lessons in Nature, From Bench to Bedside. World Allergy Organ J (2012) 0.79

Increased expression of interleukin-13 but not interleukin-4 in CD4+ cells from patients with the hyper-IgE syndrome. Clin Exp Immunol (2002) 0.79

Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Clin Dev Immunol (2010) 0.78

A Case of Hyper Immunoglobulin-E Syndrome Associated with Scrotal Tongue and Intraoral Hyperpigmentation. Indian J Dermatol (2015) 0.78

Spectrum of primary immunodeficiency disorders in Sri Lanka. Allergy Asthma Clin Immunol (2013) 0.77

Linkage/association study of a locus modulating total serum IgE on chromosome 14q13-24 in families with asthma. Thorax (2004) 0.77

Case report of a young child with disseminated histoplasmosis and review of hyper immunoglobulin e syndrome (HIES). Clin Mol Allergy (2011) 0.76

Hyper-IgE syndrome and autoimmunity in Mexican children. Pediatr Nephrol (2006) 0.76

Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients. J Clin Immunol (2014) 0.76

Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). J Clin Immunol (2010) 0.76

A rare primary immunodeficiency. BMJ Case Rep (2014) 0.75

Etiology and management of hyperimmunoglobulinemia E syndrome. Indian J Ophthalmol (2010) 0.75

Eosinophilia in an Acutely Limping Child: An Easy Guess of Rare Systemic Aetiology! J Clin Diagn Res (2016) 0.75

Hyperimmunoglobulin E syndrome in two siblings. Dermatol Reports (2011) 0.75

Hyperimmunoglobulin e syndrome presenting as osteogenesis imperfecta in a 3 year old child. Infect Dis Rep (2013) 0.75

Current Status of Dedicator of Cytokinesis-Associated Immunodeficiency: DOCK8 and DOCK2. Dermatol Clin (2017) 0.75

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis. J Exp Med (2017) 0.75

Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities. J Res Med Sci (2017) 0.75

Reduced bone density in patients with autosomal dominant hyper-IgE syndrome. J Clin Immunol (2013) 0.75

Articles cited by this

Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A (1984) 48.41

Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet (1998) 19.35

Faster sequential genetic linkage computations. Am J Hum Genet (1993) 18.83

Avoiding recomputation in linkage analysis. Hum Hered (1994) 8.39

Computer-simulation methods in human linkage analysis. Proc Natl Acad Sci U S A (1989) 7.93

A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. Am J Hum Genet (1995) 6.59

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82

The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med (1997) 5.07

Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics (1972) 3.75

An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57

Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. Lancet (1966) 3.27

Craniosynostosis update 1987. Am J Med Genet Suppl (1988) 2.21

Abnormalities in the regulation of human IgE synthesis. Immunol Rev (1978) 2.14

Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet (1974) 1.98

Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J Clin Invest (1981) 1.63

Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56

Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest (1990) 1.42

Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis, and hyperimmunoglobulinemia E. Ann Intern Med (1975) 1.36

Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol (1991) 1.30

The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature. Medicine (Baltimore) (1983) 1.28

Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci U S A (1989) 1.18

Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job's) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A. J Clin Invest (1985) 1.11

Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. J Clin Invest (1987) 1.08

The face of Job. J Pediatr (1998) 1.05

Recurrent severe staphylococcal infections, eczematoid rash, extreme elevations of IgE, eosinophilia, and divergent chemotactic responses in two generations. J Pediatr (1977) 0.98

Mononuclear cells from patients with the hyper-IgE syndrome produce little IgE when they are stimulated with recombinant human interleukin-4. J Allergy Clin Immunol (1991) 0.93

Selective deficiency of interferon-gamma production in the hyper-IgE syndrome. Relationship to in vitro IgE synthesis. Clin Exp Immunol (1991) 0.90

Evolution of the hyperimmunoglobulin E and recurrent infection (HIE, JOB's) syndrome in a young girl. J Allergy Clin Immunol (1987) 0.87

Hyperimmunoglobulinemia E syndrome: association with osteoporosis and recurrent fractures. Radiology (1985) 0.87

A boy with recurrent infections, impaired PMN-chemotaxis, increased IgE concentrations and cranial synostosis--a variant of the hyper-IgE syndrome? Helv Paediatr Acta (1987) 0.85

The interleukin-4 receptor variant Q576R in hyper-IgE syndrome. N Engl J Med (1998) 0.84

In vitro studies of the hyper-IgE disorders: suppression of spontaneous IgE synthesis by allogeneic suppressor T lymphocytes. Clin Immunol Immunopathol (1982) 0.84

Abnormalities of lymphocyte locomotion in immunodeficiency disease. Clin Exp Immunol (1983) 0.83

Immune regulation in the hyper-IgE/Job syndrome. Birth Defects Orig Artic Ser (1983) 0.81

Abnormalities in the regulation of human IgE synthesis. Ann Allergy (1982) 0.81

[The hyper-IgE-syndrome (Buckley- or Job-syndrome)]. Ergeb Inn Med Kinderheilkd (1987) 0.81

Articles by these authors

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

Protein sequence similarity searches using patterns as seeds. Nucleic Acids Res (1998) 23.87

The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03

Faster sequential genetic linkage computations. Am J Hum Genet (1993) 18.83

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet (2001) 15.27

Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17

Evaluation of radiometric system for detecting bacteremia. Appl Microbiol (1973) 6.26

Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64

Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50

Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr (1997) 5.47

Effects of sampling standardization on estimates of Phanerozoic marine diversification. Proc Natl Acad Sci U S A (2001) 5.27

An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol (1986) 5.14

Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol (1973) 4.61

Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) (2000) 4.45

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med (1999) 4.35

Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science (2001) 4.32

Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet (1998) 4.32

The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med (1995) 4.25

Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res (2001) 4.15

The regulatory role of divalent cations in human granulocyte chemotaxis. Evidence for an association between calcium exchanges and microtubule assembly. J Cell Biol (1974) 4.10

Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell (1994) 4.04

Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet (2005) 3.97

Diaphragm function and alveolar hypoventilation. Q J Med (1976) 3.94

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86

Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet (1985) 3.83

Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics (1972) 3.75

The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood (1985) 3.53

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (1987) 3.51

Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37

Structural analysis of human neutrophil migration. Centriole, microtubule, and microfilament orientation and function during chemotaxis. J Cell Biol (1977) 3.33

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32

Consensus statement on the live organ donor. JAMA (2000) 3.29

Current concepts: immunology. Neutrophils in human diseases. N Engl J Med (1987) 3.29

Effect of community-based interventions on high-risk drinking and alcohol-related injuries. JAMA (2000) 3.24

Partial V(D)J recombination activity leads to Omenn syndrome. Cell (1998) 3.18

A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal (1996) 3.18

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 3.17

Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science (1990) 3.15

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet (1999) 3.12

p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest (2001) 3.02

Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol (1985) 3.02

Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J Biol Chem (1987) 2.99

A genetic linkage map of microsatellites in the domestic cat (Felis catus). Genomics (1999) 2.99

The immunobiology of zinc. Immunol Today (1997) 2.93

Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr (1997) 2.92

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis (2003) 2.85

Intravenous cefotaxime in children with bacterial meningitis. Lancet (1980) 2.77

Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature (1986) 2.76

The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med (2001) 2.75

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74

Brain spectrin, a membrane-associated protein related in structure and function to erythrocyte spectrin. Nature (1982) 2.74

Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed (1999) 2.73

Fatal injuries to bicyclists: the experience of Dade County, Florida. J Trauma (1983) 2.73

X inactivation in females with X-linked disease. N Engl J Med (1998) 2.67

NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest (2000) 2.67

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest (1998) 2.67

Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature (1988) 2.60

Role of secretory events in modulating human neutrophil chemotaxis. J Clin Invest (1978) 2.59

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest (1999) 2.58

Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol (1975) 2.56

Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis (1998) 2.53

Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science (2001) 2.52

Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis (1980) 2.50

Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest (1978) 2.48

Fulminating vibrio parahemolyticus septicemia. A syndrome of erythemia multiforme, hemolytic anemia, and hypotension. Arch Intern Med (1974) 2.46

The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45

Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest (1975) 2.40

The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40

Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science (1989) 2.39

Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers. J Cell Biol (1986) 2.36

Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J (1998) 2.36

Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods (1995) 2.35

Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. J Immunol (1984) 2.34

An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med (1980) 2.32

Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med (1981) 2.31

Immune response after splenectomy. Lancet (1978) 2.31

Cytochrome b558: the flavin-binding component of the phagocyte NADPH oxidase. Science (1992) 2.31

High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother (1988) 2.30

Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet (1996) 2.29